Trial
NCT05655299
VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Ventyx Biosciences, Inc
Collaborators
—
Condition
Psoriasis
Intervention
VTX958 Dose A
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19